Actilyse fda：Activase® (alteplase)
Activase® (alteplase)
LearnaboutActivase®(alteplase),atreatmentforacuteischemicstroke(AIS)...FDAAccessSummarybasisofapproval.https://www.accessdata.fda.gov ...。其他文章還包含有：「ACTIVASE(alteplase)forinjection」、「CathfloActivase(Alteplase)Powderforreconstitutionforuse...」、「阿替普酶」、「Activase®GenericName」、「Actilyse」、「HumanDrugsView」、「ACTILYSE10mgpowderandsolventforsolutionfor...」、「Alteplase(C...
查看更多 離開網站
ACTIVASE (alteplase) for injection
https://www.accessdata.fda.gov
ACTIVASE. Acute Myocardial Infarction or Pulmonary Embolism. • History of recent stroke. (4.2). ACTIVASE (alteplase) for injection, for ...
Cathflo Activase (Alteplase) Powder for reconstitution for use ...
https://www.accessdata.fda.gov
(Alteplase) is a tissue plasminogen activator (t-PA) produced by recombinant DNA technology. It is a sterile, purified glycoprotein of 527 amino acids.
阿替普酶
https://zh.wikipedia.org
Activase、Actilyse、Cathflo Activase及其他。 其他名稱, t-PA, rt-PA. AHFS/Drugs ... ^ Activase: FDA-Approved Drugs. U.S. Food and Drug Administration (FDA) ...
Activase® Generic Name
https://www.accessdata.fda.gov
ACTIVASE. Acute Myocardial Infarction or Pulmonary Embolism. • History of recent stroke. (4.2). ACTIVASE (alteplase) for injection, for ...
Actilyse
https://www.ema.europa.eu
On 30 September 2002, the European Commission issued a Decision valid throughout the European Union for the medicinal product Actilyse, which contains ...
Human Drugs View
https://verification.fda.gov.p
Generic Name, Alteplase ; Brand Name, Actilyse ; Dosage Strength, 50 mg ; Dosage Form, Powder for Solution for Infusion (IV ; Classification, Prescription Drug (RX).
ACTILYSE 10 mg powder and solvent for solution for ...
https://www.medsafe.govt.nz
ACTILYSE is indicated for thrombolytic treatment of acute ischaemic stroke. Treatment must be started as early as possible within 4.5 hours after onset of ...
Alteplase (CathFlo Activase)
https://www.accessdata.fda.gov
Cathflo ä Activase â. 2. [Alteplase]. 3. Powder for reconstitution for use in central venous access. 4 devices. 5. DESCRIPTION.